Search results for "Suppression"

showing 10 items of 404 documents

Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression

2021

Coronavirus disease 2019 (COVID-19) rapidly spread from China as a pandemic, with Italy one of the most affected countries worldwide. Unlike adults, children have a milder presentation of COVID-19, even when affected by CKD or on immunosuppressive therapy for glomerulopathies and kidney

2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Epidemiologymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibodies ViralCritical Care and Intensive Care MedicineIdiopathic Nephrotic SyndromeImmunoglobulin GPandemicPrevalenceResearch LetterHumansMedicineRenal Insufficiency ChronicChildImmunosuppression TherapyTransplantationbiologySARS-CoV-2business.industryCOVID-19InfantImmunosuppressionNephrologyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusinessClinical Journal of the American Society of Nephrology
researchProduct

Visual mismatch negativity (vMMN): A review and meta-analysis of studies in psychiatric and neurological disorders

2016

The visual mismatch negativity (vMMN) response is an event-related potential (ERP) component, which is automatically elicited by events that violate predictions based on prior events. VMMN experiments use visual stimulus repetition to induce predictions, and vMMN is obtained by subtracting the response to rare unpredicted stimuli from those to frequent stimuli. One increasingly popular interpretation of the mismatch response postulates that vMMN, similar to its auditory counterpart (aMMN), represents a prediction error response generated by cortical mechanisms forming probabilistic representations of sensory signals. Here we discuss the physiological and theoretical basis of vMMN and review…

2805 Cognitive Neurosciencespecific adaptation (SSA)skitsofrenia3205 Experimental and Cognitive Psychologyeffect sizerepetition suppression (RS)610 Medicine & healthStimulusRepetition suppression (RS)stimulus specific adaptation (SSA)170 Ethics3206 Neuropsychology and Physiological Psychologyschizophreniavisual mismatch negativity (vMMN)10237 Institute of Biomedical EngineeringVisual mismatch negativity (vMMN)
researchProduct

Splenic Littoral Cell Hemangioendothelioma in a Patient With Crohn's Disease Previously Treated With Immunomodulators and Anti-TNF Agents: A Rare Tum…

2011

Th e risk of malignancy in Crohn ’ s disease (CD) has been well described. Moreover, immunomodulators, uch as azathioprine (AZA) and 6-mercaptopurine (6-MP), and biological agents, such as infl iximab and adalimumab, may promote carcinogenesis ( 1 – 3 ). Splenic littoral cell tumors are recently described tumors of vascular origin composed of endothelial cells, with typical microscopic and immunohistochemical features of splenic sinus lining cells ( 4 ). Clinical findings are not specific, and outcome is unpredictable but usually benign, although a few cases with a malignant behavior have been reported ( 5,6 ). We report a 58-year-old Caucasian man with a long history of ileocolonic CD.

6-MercaptopurineMalePathologymedicine.medical_specialtyColonic Diseasemedicine.medical_treatmentAzathioprineSplenic NeoplasmHemangioendotheliomaHemangiomaImmunosuppressive AgentImmunocompromised HostImmunologic FactorCrohn Disease6-Mercaptopurine; Azathioprine; Colonic Diseases; Crohn Disease; Gastrointestinal Agents; Hemangioendothelioma; Hemangioma; Humans; Ileal Diseases; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Splenic Neoplasms; Tumor Necrosis Factor-alpha; Immunocompromised Host; GastroenterologyAzathioprineGastrointestinal AgentMedicineGastrointestinal agentCrohn's diseaseHepatologyTumor Necrosis Factor-alphabusiness.industryGastroenterologyImmunosuppressionMiddle Agedmedicine.diseaseSplenic NeoplasmHemangioendotheliomaImmunologyIleal DiseaseTumor necrosis factor alphaHemangiomabusinessHumanmedicine.drugAmerican Journal of Gastroenterology
researchProduct

Energy dependence of the transverse momentum distributions of charged particles in pp collisions measured by ALICE

2013

Differential cross sections of charged particles in inelastic pp collisions as a function of $p_{\rm T}$ have been measured at $\sqrt{s}=$ 0.9, 2.76 and 7 TeV at the LHC. The $p_{\rm T}$ spectra are compared to NLO-pQCD calculations. Though the differential cross section for an individual $\sqrt{s}$ cannot be described by NLO-pQCD, the relative increase of cross section with $\sqrt{s}$ is in agreement with NLO-pQCD. Based on these measurements and observations, procedures are discussed to construct pp reference spectra at $\sqrt{s} =$ 2.76 and 5.02 TeV up to $p_{\rm T}$ = 50 GeV/$c$ as required for the calculation of the nuclear modification factor in nucleus-nucleus and proton-nucleus coll…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Physics and Astronomy (miscellaneous)heavy ion collisionsNuclear Theory01 natural sciences7. Clean energySpectral lineHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)pp collisionALICEpp collisions; transverse momentum; ALICE[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Experiment (nucl-ex)transverse momentum distributionNuclear ExperimentNuclear ExperimentPhysicsLarge Hadron Collidertransverse momentum; pp; ALICE; charged particlesPhysicsCharged particle3. Good health:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]:Nuclear and elementary particle physics: 431 [VDP]Transverse momentumLhcDiffractionpp collisionsParticle Physics - ExperimentRegular Article - Experimental PhysicsVDP::Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431particle productionFOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]transverse momentumtransverse momentum distribution; PP COLLISIONSNuclear physicsRoot-S(Nn)=2.76 TevCross section (physics)0103 physical sciencesNuclear Physics - ExperimentPb-Pb Collisions010306 general physicsEngineering (miscellaneous)SuppressionALICE experiment; particle production; heavy ion collisionsVDP::Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyTransverse momentum distributions:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]ALICE experimentFunction (mathematics)Proton-Proton Collisionsp-p collisionHigh Energy Physics::ExperimentALICE (propellant)Energy (signal processing)
researchProduct

Transverse momentum spectra and nuclear modification factors of charged particles in pp, p-Pb and Pb-Pb collisions at the LHC

2018

We report the measured transverse momentum ($p_{\rm T}$) spectra of primary charged particles from pp, p-Pb and Pb-Pb collisions at a center-of-mass energy $\sqrt{s_{\rm NN}} = 5.02$ TeV in the kinematic range of $0.15<p_{\rm T}<50$ GeV/$c$ and $|\eta|< 0.8$. A significant improvement of systematic uncertainties motivated the reanalysis of data in pp and Pb-Pb collisions at $\sqrt{s_{\rm NN}} = 2.76$ TeV, as well as in p-Pb collisions at $\sqrt{s_{\rm NN}} = 5.02$ TeV, which is also presented. Spectra from Pb-Pb collisions are presented in nine centrality intervals and are compared to a reference spectrum from pp collisions scaled by the number of binary nucleon-nucleon collisions. For cent…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]heavy ion: scatteringHadronmomentum [up]binaryMULTIPLICITY DEPENDENCEPartonheavy ion: scattering ; transverse momentum: momentum spectrum ; quantum chromodynamics: matter ; parton: energy loss ; momentum: high ; up: momentum ; pp: scattering ; nucleus ; charged particle ; suppression ; energy dependence ; impact parameter ; transport theory ; nucleon nucleon ; CERN LHC Coll ; kinematics ; binarymomentum spectrum [transverse momentum]hiukkasfysiikkaKAONnucl-ex01 natural sciences7. Clean energy2760 GeV-cms/nucleonHigh Energy Physics - Experimenttransverse momentum: momentum spectrumHeavy Ion Experiments; Heavy-ion collision; Nuclear and high energy physicsHigh Energy Physics - Experiment (hep-ex)quark gluon plasma Heavy Ion Experiments Heavy-ion collisionnucleon nucleonHeavy-ion collisionhigh [momentum]PIONscattering [p p]transport theory[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex][ PHYS.NEXP ] Physics [physics]/Nuclear Experiment [nucl-ex]Nuclear Experiment (nucl-ex)impact parameterNuclear ExperimentNuclear ExperimentQCD matterparticle production and suppressionPhysicsPhysicsHADRONSheavy ion experiments heavy ion collision particle production and suppressionHeavy Ion Experiments; Heavy-ion collisionVDP::Kjerne- og elementærpartikkelfysikk: 431suppressionCENTRALITY DEPENDENCEcharged particleCharged particleMULTIPLICITY DEPENDENCE; CENTRALITY DEPENDENCE; HADRONS; SUPPRESSION; MODEL; KAON; PIONquark gluon plasma:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]:Nuclear and elementary particle physics: 431 [VDP]CERN LHC CollVDP::Nuclear and elementary particle physics: 431kinematicsHeavy Ion ExperimentImpact parameterParticle Physics - ExperimentHeavy Ion Experiments Heavy-ion collision Nuclear and High Energy Physics.Nuclear and High Energy Physicsp p: scatteringnucleon nucleon: scatteringenergy loss [parton]FOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]114 Physical sciencesenergy dependenceNuclear physicsPionHeavy Ion Experiments[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]scattering [heavy ion]0103 physical sciencesmatter [quantum chromodynamics]lcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530Nuclear Physics - Experiment5020 GeV-cms/nucleonup: momentum010306 general physicsp nucleus: scatteringquantum chromodynamics: matterta114010308 nuclear & particles physicshep-exnucleus:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]Nuclear and high energy physicsheavy ion collisionMODEL* Automatic Keywords *13. Climate actionmomentum: highQuark–gluon plasmalcsh:QC770-798High Energy Physics::Experimentparton: energy lossEnergy (signal processing)experimental results
researchProduct

Der gegenwärtige Stand der Blutfiltration - Grundlagen und klinische Bedeutung von Leukozytendepletions- und Mikroaggregatfiltern bei der Bluttransfu…

1993

In this review the role of the latest generation of leukodepletion blood filters and the adverse reaction of leukocytes i.e. alloimmunisation, immunosuppression, nonhaemolytic febrile transfusion reaction, platelet refractoriness, transmission of infectious agents are described and discussed. Leukocyte-poor blood component is indicated for patients with a history of nonhaemolytic febrile transfusion reaction, in avoiding alloimmunisation in patients waiting for transplantation or platelet refractoriness and in preventing CMV-infection. In the review the role of microaggregate filters in transfusion complications, namely, nonhaemolytic febrile transfusion reaction, thrombocytopenia, adult re…

ARDSBlood transfusionRespiratory distressbusiness.industrymedicine.medical_treatmentImmunosuppressionGeneral MedicineCritical Care and Intensive Care Medicinemedicine.diseaseBlood cellTransplantationAnesthesiology and Pain Medicinemedicine.anatomical_structureBlood productIntensive careImmunologyEmergency MedicinemedicinebusinessAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

2011

Abstract Extracellular adenosine (ADO), generated from ATP or ADP through the concerted action of the ectoenzymes CD39 and CD73, elicits autocrine and paracrine effects mediated by type 1 purinergic receptors. We have tested whether the expression of CD39 and CD73 by chronic lymphocytic leukemia (CLL) cells activates an adenosinergic axis affecting growth and survival. By immunohistochemistry, CD39 is widely expressed in CLL lymph nodes, whereas CD73 is restricted to proliferation centers. CD73 expression is highest on Ki-67+ CLL cells, adjacent to T lymphocytes, and is further localized to perivascular areas. CD39+/CD73+ CLL cells generate ADO from ADP in a time- and concentration-dependen…

AdenosineCellular differentiationChronic lymphocytic leukemia5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Antigens CD; Antineoplastic Agents Phytogenic; Apyrase; Autocrine Communication; Cell Death; Cell Differentiation; Cell Movement; Cell Survival; Etoposide; Extracellular Space; GPI-Linked Proteins; Humans; Leukemia Lymphocytic Chronic B-Cell; Paracrine Communication; Receptor Adenosine A2A; Tumor Cells Cultured; Biochemistry; Immunology; Hematology; Cell BiologyMICROENVIRONMENTCD38BiochemistryACTIVATIONAdenosine TriphosphateCell MovementPhytogenichemic and lymphatic diseasesTumor Cells CulturedChronic5'-NucleotidaseEtoposideLeukemiaCulturedCell DeathTUMOR-GROWTHApyrasePurinergic receptorCell DifferentiationHematologyLymphocyticCDTumor CellsCell biologyAdenosine DiphosphateAutocrine CommunicationLeukemiaReceptorIMMUNE SUPPRESSIONReceptor Adenosine A2ACell SurvivalImmunologyAntineoplastic AgentsAdenosinergicBiologyGPI-Linked ProteinsDAMAGE-INDUCED APOPTOSISAdenosine A2AParacrine signallingAntigens CDParacrine CommunicationmedicineHumansAntigensAutocrine signallingImmunobiologyB-CellCell BiologyDAMAGE-INDUCED APOPTOSIS; T-CELLS; IMMUNE SUPPRESSION; ZAP-70 EXPRESSION; TUMOR-GROWTH; RECEPTOR; CD73; ACTIVATION; CD38; MICROENVIRONMENTmedicine.diseaseAntineoplastic Agents PhytogenicLeukemia Lymphocytic Chronic B-CellSettore MED/15 - MALATTIE DEL SANGUET-CELLSCD73Extracellular SpaceZAP-70 EXPRESSIONCD38Blood
researchProduct

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells

2015

Multiple sclerosis (MS) is an inflammatory autoimmune disease characterized by imbalanced immune regulatory networks, and MS patient-derived T effector cells are inefficiently suppressed through regulatory T cells (Treg), a phenomenon known as Treg resistance. In the current study we investigated T cell function in MS patients before and after interferon-beta therapy. We compared cytokine profile, responsiveness for Treg-mediated suppression ex vivo and evaluated reactivity of T cells in vivo using a humanized mouse model. We found that CD4+ and CD8+ T cells of therapy-naive MS patients were resistant to Treg-mediated suppression. Treg resistance is associated with an augmented IL-6 product…

AdultAdolescentdiagnosisReceptor expressionT cellchemical and pharmacologic phenomenaMice SCIDAntibodies Monoclonal Humanizedmultiple sclerosisT-Lymphocytes RegulatoryCatalysisArticleInorganic ChemistryTCIRG1lcsh:ChemistryInterleukin 21Young AdultImmune systemCytotoxic T cellMedicineAnimalsHumansIL-2 receptorPhysical and Theoretical ChemistryMolecular BiologyT effector cellslcsh:QH301-705.5SpectroscopyImmunosuppression TherapyInflammationtherapybusiness.industryOrganic Chemistryimmune regulationGeneral MedicineInterferon-betaMiddle AgedReceptors Interleukin-6Computer Science ApplicationsTregmedicine.anatomical_structureAnimals Newbornlcsh:Biology (General)lcsh:QD1-999ImmunologyLeukocytes MononuclearbusinessCD8International Journal of Molecular Sciences
researchProduct

Time-dependent changes in serum 3α-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression

1995

The clinical utility of serum 3 alpha-androstanediol glucuronide level has been controversial. Among the concerns regarding its lack of utility has been the finding that suppression of serum 3 alpha-androstanediol glucuronide does not occur readily with treatment. We hypothesized that because the treatment of hirsutism requires a prolonged duration, a longer observation period is required for changes in serum 3 alpha-androstanediol glucuronide to be measured. Therefore, we studied the clinical and hormonal changes in 11 women treated for hirsutism with a gonadotropin-releasing hormone agonist (GnRH-a) for 1 year. A progressive reduction in Ferriman-Gallwey scores occurred, which was signifi…

AdultAgonistHirsutismmedicine.medical_specialtyAndrosterone glucuronidemedicine.drug_classEndocrinology Diabetes and MetabolismObservation period3-alpha-androstanediol glucuronideAndrosteroneEndocrinologyOvarian suppressionInternal medicinemedicineHumansTestosteronehirsutismTriptorelin Pamoatebusiness.industryObstetrics and Gynecologymedicine.diseaseAndrostane-317-diolEndocrinologyFemaleGlucuronidebusinessPolycystic Ovary SyndromeHormoneGynecological Endocrinology
researchProduct

Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent di…

2005

We describe the results of the first study to show that adult rat and human islets can be protected against xenogenic rejection in immunocompetent diabetic mice by encapsulating them in a novel alginate-based microcapsule system with no additional permselective membrane. Nonencapsulated islets lost function within 4–8 days after being transplanted into diabetic Balb/c mice, whereas transplanted encapsulated adult rat or human islets resulted in normoglycemia for &amp;gt;7 months. When rat islet grafts were removed 10 and 36 weeks after transplantation, the mice became immediately hyperglycemic, thus demonstrating the efficacy of the encapsulated islets. The explanted capsules showed only a …

AdultBlood GlucoseMaleendocrine systemmedicine.medical_specialtyTime FactorsRatónAlginatesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIslets of Langerhans TransplantationCapsulesGraft functionIslets of LangerhansMiceGlucuronic AcidDiabetes mellitusInternal medicineInsulin SecretionInternal MedicineDiabetes MellitusMedicineAnimalsHumansInsulinInsulin secretiongeographyMice Inbred BALB Cgeography.geographical_feature_categorybusiness.industryHexuronic AcidsGraft SurvivalImmunosuppressionDiabetic mousemedicine.diseaseIsletRatsTransplantationEndocrinologybusinessDiabetes
researchProduct